Effects of Spirulina supplementation in patients with ulcerative colitis: a double-blind, placebo-controlled randomized trial.

Authors:
Moradi S; Bagheri R; Amirian P; Zarpoosh M; Cheraghloo N and 3 more

Journal:
BMC Complement Med Ther

Publication Year: 2024

DOI:
10.1186/s12906-024-04400-w

PMCID:
PMC10905931

PMID:
38424572

Journal Information

Journal Title: BMC Complement Med Ther

Detailed journal information not available.

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll study protocols were carried out according to the Declaration of Helsinki. All patients provided written informed consent before participation in the trial. The study protocol was approved by the ethical committee at the Isfahan University of Medical Sciences (code: IR.MUI.RESEARCH.REC.1398.436, approval date 23/10/2019) and registered online at http://www.IRCT.ir (code: IRCT20191204045612N1, register date 05/04/2021). Consent for publicationAll authors have agreed to submit the manuscript to BMC Complementary Medicine and Therapies. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding The current work is a part of a PhD thesis supported by a grant (No.398533) from the Vice-Chancellor for Research at Isfahan University of Medical Sciences in Iran."

Evidence found in paper:

"Declarations: Ethics approval and consent to participateAll study protocols were carried out according to the Declaration of Helsinki. All patients provided written informed consent before participation in the trial. The study protocol was approved by the ethical committee at the Isfahan University of Medical Sciences (code: IR.MUI.RESEARCH.REC.1398.436, approval date 23/10/2019) and registered online at http://www.IRCT.ir (code: IRCT20191204045612N1, register date 05/04/2021).: Consent for publicationAll authors have agreed to submit the manuscript to BMC Complementary Medicine and Therapies.: Competing interestsThe authors declare no competing interests. Ethics approval and consent to participate: All study protocols were carried out according to the Declaration of Helsinki. All patients provided written informed consent before participation in the trial. The study protocol was approved by the ethical committee at the Isfahan University of Medical Sciences (code: IR.MUI.RESEARCH.REC.1398.436, approval date 23/10/2019) and registered online at http://www.IRCT.ir (code: IRCT20191204045612N1, register date 05/04/2021)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025